Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
83%(5 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_2
5
63%
Ph phase_3
1
13%
Ph phase_1
2
25%

Phase Distribution

2

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
5(62.5%)
Phase 3Large-scale testing
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (25.0%)
Phase 25 (62.5%)
Phase 31 (12.5%)

Trials by Status

completed675%
terminated113%
unknown113%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_3

A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

NCT00532155
terminatedphase_2

Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy

NCT00480857
completedphase_2

Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer

NCT00231465
completedphase_1

Docetaxel and Sirolimus in Patients With Advanced Malignancies

NCT01054313
unknownphase_2

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

NCT01380275
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT00532155Phase 3

A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

Completed
NCT00480857Phase 2

Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy

Terminated
NCT00231465Phase 2

Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer

Completed
NCT01054313Phase 1

Docetaxel and Sirolimus in Patients With Advanced Malignancies

Completed
NCT01380275Phase 2

Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.

Unknown
NCT00077857Phase 2

A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer

Completed
NCT00296816Phase 2

TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary

Completed
NCT00703378Phase 1

Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8